R. Bryan Riggsbee's most recent trade in Caredx Inc was a trade of 12,103 Common Stock done . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caredx Inc | R. Bryan Riggsbee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 12,103 | 29,517 (0%) | 0% | 0 | Common Stock | |
| Caredx Inc | R. Bryan Riggsbee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | R. Bryan Riggsbee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,048 | 16,048 | - | - | Stock Option (right to buy) | |
| Caredx Inc | R. Bryan Riggsbee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 10,570 | 17,414 (0%) | 0% | 0 | Common Stock | |
| Caredx Inc | R. Bryan Riggsbee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 9,760 | 9,760 | - | - | Stock Option (right to buy) | |
| Caredx Inc | R. Bryan Riggsbee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 9,760 | 9,760 | - | - | Stock Option (right to buy) | |
| Caredx Inc | R. Bryan Riggsbee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 6,844 | 6,844 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.09 per share. | 01 Dec 2023 | 30,000 | 291,812 (0%) | 0% | 19.1 | 572,835 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.72 per share. | 24 Mar 2023 | 5,307 | 368,665 (0%) | 0% | 23.7 | 125,882 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.72 per share. | 24 Mar 2023 | 3,622 | 373,972 (0%) | 0% | 23.7 | 85,914 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.91 per share. | 22 Mar 2023 | 4,074 | 377,594 (0%) | 0% | 22.9 | 93,335 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 43,783 | 381,668 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.55 per share. | 02 Mar 2023 | 15,000 | 337,885 (0%) | 0% | 22.6 | 338,253 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.42 per share. | 18 Feb 2023 | 11,222 | 352,885 (0%) | 0% | 19.4 | 217,931 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 20 Jan 2023 | 9,400 | 364,107 (0%) | 0% | 20.0 | 188,386 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 18 Jan 2023 | 600 | 373,507 (0%) | 0% | 20.0 | 12,006 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.15 per share. | 27 Dec 2022 | 20,000 | 374,107 (0%) | 0% | 15.1 | 302,992 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.62 per share. | 09 Oct 2022 | 7,411 | 394,107 (0%) | 0% | 19.6 | 145,404 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.62 per share. | 09 Oct 2022 | 4,974 | 401,518 (0%) | 0% | 19.6 | 97,590 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.69 per share. | 25 Sep 2022 | 5,263 | 411,035 (0%) | 0% | 18.7 | 98,365 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.41 per share. | 25 Sep 2022 | 4,543 | 406,492 (0%) | 0% | 18.4 | 83,637 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.89 per share. | 25 Aug 2022 | 3,056 | 416,298 (0%) | 0% | 24.9 | 76,064 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Aug 2022 | 2,150 | 419,354 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.32 per share. | 24 Mar 2022 | 5,323 | 421,504 (0%) | 0% | 25.3 | 134,778 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.32 per share. | 24 Mar 2022 | 3,633 | 426,827 (0%) | 0% | 25.3 | 91,988 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 36,866 | 430,460 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 48,009 | 404,774 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.69 per share. | 16 Feb 2022 | 11,180 | 393,594 (0%) | 0% | 25.7 | 287,214 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.88 per share. | 09 Oct 2021 | 7,419 | 356,765 (0%) | 0% | 30.9 | 229,099 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.88 per share. | 09 Oct 2021 | 4,979 | 364,184 (0%) | 0% | 30.9 | 153,752 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.31 per share. | 25 Sep 2021 | 11,907 | 373,704 (0%) | 0% | 33.3 | 396,622 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.31 per share. | 25 Sep 2021 | 4,541 | 369,163 (0%) | 0% | 33.3 | 151,261 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 66,977 | 385,611 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Aug 2021 | 3,250 | 321,692 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.81 per share. | 25 Aug 2021 | 3,058 | 318,634 (0%) | 0% | 34.8 | 106,449 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.14 per share. | 03 Aug 2021 | 14,983 | 324,942 (0%) | 0% | 35.1 | 526,476 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 32,774 | 339,925 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 29.69 per share. | 18 Feb 2021 | 11,175 | 307,151 (0%) | 0% | 29.7 | 331,786 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2020 | 44,954 | 318,326 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 13.04 per share. | 30 Sep 2020 | 6,653 | 273,372 (0%) | 0% | 13.0 | 86,755 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 41,000 | 296,491 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 12.44 per share. | 24 Sep 2020 | 6,653 | 284,571 (0%) | 0% | 12.4 | 82,763 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 12.44 per share. | 24 Sep 2020 | 5,267 | 291,224 (0%) | 0% | 12.4 | 65,521 | Common Stock |
| Myriad Genetics, Inc. | R. Bryan Riggsbee | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 12.44 per share. | 24 Sep 2020 | 4,546 | 280,025 (0%) | 0% | 12.4 | 56,552 | Common Stock |